- Home
- LGCY vs PYXS Comparison
LGCY vs PYXS Comparison
Compare LGCY & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCY
- PYXS
- Stock Information
- Founded
- LGCY 2009
- PYXS 2018
- Country
- LGCY United States
- PYXS United States
- Employees
- LGCY N/A
- PYXS N/A
- Industry
- LGCY
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- LGCY
- PYXS Health Care
- Exchange
- LGCY NYSE
- PYXS Nasdaq
- Market Cap
- LGCY 101.9M
- PYXS 101.1M
- IPO Year
- LGCY 2024
- PYXS 2021
- Fundamental
- Price
- LGCY $8.73
- PYXS $1.50
- Analyst Decision
- LGCY Strong Buy
- PYXS Strong Buy
- Analyst Count
- LGCY 2
- PYXS 8
- Target Price
- LGCY $9.35
- PYXS $9.43
- AVG Volume (30 Days)
- LGCY 100.1K
- PYXS 817.5K
- Earning Date
- LGCY 11-14-2024
- PYXS 11-12-2024
- Dividend Yield
- LGCY N/A
- PYXS N/A
- EPS Growth
- LGCY 90.87
- PYXS N/A
- EPS
- LGCY 0.63
- PYXS N/A
- Revenue
- LGCY $49,638,473.00
- PYXS $16,146,000.00
- Revenue This Year
- LGCY $32.23
- PYXS N/A
- Revenue Next Year
- LGCY $20.60
- PYXS N/A
- P/E Ratio
- LGCY $13.84
- PYXS N/A
- Revenue Growth
- LGCY 32.36
- PYXS N/A
- 52 Week Low
- LGCY $3.60
- PYXS $1.39
- 52 Week High
- LGCY $10.37
- PYXS $6.85
- Technical
- Relative Strength Index (RSI)
- LGCY N/A
- PYXS 36.16
- Support Level
- LGCY N/A
- PYXS $1.39
- Resistance Level
- LGCY N/A
- PYXS $1.82
- Average True Range (ATR)
- LGCY 0.00
- PYXS 0.10
- MACD
- LGCY 0.00
- PYXS 0.03
- Stochastic Oscillator
- LGCY 0.00
- PYXS 25.58
About LGCY LEGACY EDUCATION INC
Legacy Education Inc is engaged in career-focused, post-secondary education services to students at all stages of adult life, from recent high school graduates to working parents.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.